Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: Results are inconclusive

Australian and New Zealand Journal of Public Health

Volumn 35, Issue 2, 2011, Pages 180-186

  Mogasale, Vittal ^a   Barendregt, Jan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cost effectiveness; Economic evaluation; Influenza vaccination

Indexed keywords

INFLUENZA VACCINE;

AGE; ARTICLE; AUSTRALIA; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFLUENZA; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VACCINATION;

AGE FACTORS; AUSTRALIA; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; VACCINATION;

EID: 79959870532     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2010.00639.x     Document Type: Article

References (40)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-40. (Pubitemid 39223224)
2. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87(12):1944-50. (Pubitemid 28055910)
3. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000;181(3):831-7. (Pubitemid 30194462)
4. World Health Organisation. Influenza, Fact sheet No. 211 [factsheet on the Internet]. Geneva (CHE) Media Center, WHO; 2003 March [cited 2008 May 28]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en
5. National Hospital Morbidity Database [database on the Internet]. Canberra (AUST): AIHW; 2008 [cited 2008 May 28]. Statistics by Principal Diagnosis in ICD-10-AM, Australia, 1998-99 to 2004-05. Available from: http://www.aihw. gov. au/cognos/cgi-bin/ppdscgi?DC=Q&E=/ahs/principaldiagnosis9899-0405
6. Australian Bureau of Statistics [database on the Internet]. Canberra (AUST): ABS; 2008 [cited 2008 May 28]. 3303.0 - Causes of Deaths, Australia, 2006. Available from: http://www8.abs.gov. au/AUSSTATS/abs@nsf/DetailsPage/3 303.02006?OpenDocument
7. Irwin DE, Weatherby LB, Wen-Yi H, Rosenberg DM, Cook SF, Walker AM. Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv Res. 2001;1:8.
8. Fleming DM, Cross K W, Pannell RS. Influenza and its relationship to circulatory disorders. Epidemiol Infect. 2005;133(2):255-62. (Pubitemid 40439305)
9. Jefferson T, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 2, 2007. Chichester (UK): John Wiley & Sons; 2007.
10. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 9th ed. Canberra (AUST): Commonwealth Department of Health and Ageing; 2008.
11. Pharmaceutical Benefits Scheme. Schedule of Pharmaceutical Benefits for Approved Pharmacist and Medical Practitioners. Canberra (AUST): Commonwealth Department of Health and Ageing; 2003.
12. Australian Institute of Health and Welfare. 2003 Influenza Vaccine Survey: Summary Results. Canberra (AUST): AIHW; 2004. AIHW Catalogue No.: PHE 51.
13. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003;52(RR-8): 1-34; quiz CE1-4.
14. Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, Nicholson KG. The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age. Vaccine. 2006;24(7):1035-43. (Pubitemid 43185322)
15. Maciosek M V, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J Prev Med. 2006;31(1):72-9. (Pubitemid 43956594)
16. Aballea S, De Juanes JR, Barbieri M, Martin M, Chancellor J, Oyaguez I, et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine. 2007;25(39-40):6900-10. (Pubitemid 47391104)
17. Aballea S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, et al. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health. 2007;10(2):98-116. (Pubitemid 46481137)
18. Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR. The costeffectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine. 2008;26(17):2142-53.
19. Fielding JE, Miller ER, Adams J, Hawking B, Grant K, Kelly HA. Influenza surveillance in Victoria, 2006. Commun Dis Intell. 2007;31(1):100-6.
20. Fleming DM. The prediction of epidemics of respiratory infection. Eur J Epidemiol. 1994;10(4):481-3. (Pubitemid 24339221)
21. O'Brien K, Barr IG. Annual report of the National Influenza Surveillance Scheme, 2006. Commun Dis Intell. 2007;31(2):167-79.
22. World Health Organisation. A Practical Guide for Designing and Conducting Influenza Disease Burden Studies. Geneva (CHE): WHO; 2008 November.
23. Thursky K, Cordova S P, Smith D, Kelly H. Working towards a simple case definition for influenza surveillance. J Clin Virol. 2003;27(2):170-9. (Pubitemid 37329338)
24. Zambon MC, Stockton JD, Clewley J P, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358(9291):1410-6. (Pubitemid 33055743)
25. Kelly H, Birch C. The causes and diagnosis of influenza-like illness. Aust Fam Physician. 2004;33(5):305-9.
26. Fleming DM, Cross K W. Respiratory syncytial virus or influenza? Lancet. 1993;342(8886-8887):1507-10. (Pubitemid 23362166)
27. Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics. 2008;26(3):191-215. (Pubitemid 351271379)
28. Vos T, Carter R, Doran C, Anderson I, Lopez A, Wilson A. Assessing costeffectiveness in the prevention of non-communicable disease (ACE-Prevention) Project 2005-09. In: Economic Evaluation Protocol for ACE Prevention 2007 [report on the Internet]. Brisbane (AUST): Centre for Burden of Disease and Cost Effectiveness, University of Brisbane; [cited 2010 March 3]. Available from: http://www.uq.edu.au/bodce/index.html?page=43983&pid=37712
29. Australian Bureau of Statistics. Australian Demographic Statistics. Canberra (AUST): Australian Bureau of Statistics; 2003.
30. Begg S, Vos T, Barker B, et al. The Burden of Disease and Injury in Australia 2003. Canberra (AUST): Australian Institute for Health and Welfare; 2007.
31. Australian Institute of Health and Welfare. SAND Abstract No. 27 from the BEACH program 2001-2002: Prevalence and Management of Influenza. Sydney (AUST): AIHW; 2002.
32. Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR. Influenza among patients aged 50-64 years in general practice 2000-2006. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine. 2008;26:2142-53.
33. Jefferson TO, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults (Cochranes Review). In: The Cochrane Database of Systematic Reviews, Issue 3, 2006. Chichester (UK): John Wiley & Sons; 2006.
34. Barker WH, Mullooly J P. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112(6):798-811.
35. Medicare Benefits Schedule. Medicare Benefits Schedule Book. Canberra (AUST): Commonwealth Department of Health and Ageing; 2003.
36. Britt H, Miller GC, Knox S, Charles J, Valenti L, Pan Y, et al. General Practice Activity in Australia 2003-04. Canberra (AUST): Australian Institute of Health and Welfare; 2004. AIHW Catalogue No.: GEP 16.
37. MIMS. MIMS Online Australia [database on the Internet]. Sydney (AUST): MIMS Australia & UBM Medica; 2008 [cited 2008 May 21]. Available from: http://www.mims.com.au
38. Lenglet AD, Hernando V, Rodrigo P, Larrauri A, Donado JD, de Mateo S. Impact of flu on hospital admissions during 4 flu seasons in Spain, 2000-2004. BMC Public Health. 2007;7(147):197.
39. Department of Health and Ageing. Public Sector Estimated Cost Weights Round 8 AR-DRG v5.0. In: National Hospital Cost Data Collection, Round 8 (2003-2004) Cost Reports Version 4.2 and Version 5.0 [database on the Internet]. Canberra (AUST): Commonwealth of Australia; 2004 [cited 2008 May 21]. Available from: http://www.health.gov. au/internet/main/publishing.nsf/Content/ BB918453BBAB7AB0CA2570C1000230B0
40. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford (UK): Oxford University Press; 2006.